Evidence map›Paper›PMID 26467057›Full record

ArticleInternational journal of immunopathology and pharmacology2015

Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage.

K M Sannegowda, S H Venkatesha, K D Moudgil

Open access · greenAbstract read
In one paragraph

Article in International journal of immunopathology and pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Heliyon · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Integrated omics analysis revealed theJournal of diabetes and metabolic disorders · 2022
    Article
  9. Deciphering the mechanism ofFrontiers in pharmacology · 2022
    Article
  10. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.Environmental science and pollution research international · 2021
    Review
  11. Intervention of Ayurvedic drugJournal of diabetes and metabolic disorders · 2020
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

K M SannegowdaDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA Department of Biochemistry, Government College for Women, Mandya, Karnataka, India.
S H VenkateshaDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
K D MoudgilDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA Division of Rheumatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA kmoudgil@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Immune Modulation of Autoimmunity by Herbal ProductsR01AT004321 · NCCIH · UNIVERSITY OF MARYLAND BALTIMORE · PI MOUDGIL, KAMAL D · 2009 to 2012
$1.5M
NCCIH NIH HHS R01 AT004321
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints leading to tissue damage. Despite the availability of potent drugs including the biologics, many patients fail to respond to them, whereas others suffer adverse effects following long-term use of these drugs. Accordingly, the use of natural herbal products by RA patients has been increasing over the years. However, limited information about the mechanism of action of these natural products is a major shortcoming that prevents the widespread acceptance of herbal therapy by professionals and patients alike. In this study, we demonstrated the anti-arthritic activity of Tinospora cordifolia extract (TCE) using the rat adjuvant-induced arthritis model of human RA and elaborated the immune mechanisms underlying this effect. TCE treatment suppressed arthritic inflammation and bone and cartilage damage. The anti-inflammatory effect of TCE was mediated via reduction of the pro-inflammatory cytokines such as: IL-1β, TNF-α, IL-6, and IL-17; the frequency of IL-17-producing T cells; and the production of chemokines such as RANTES. Furthermore, TCE treatment limited bone damage by shifting the balance of mediators of bone remodeling (e.g., receptor activator of nuclear factor-kB ligand [RANKL] and MMP-9) in favor of anti-osteoclastic activity. Our results suggest that TCE and its bioactive components should be evaluated for their utility as therapeutic adjuncts to conventional drugs against RA.

Indexed as

PhytotherapyTinosporaAnimalsAnti-Inflammatory AgentsArthritis, RheumatoidBone RemodelingInflammation MediatorsInterferon-gammaInterleukin-17MaleMatrix Metalloproteinase InhibitorsPlant ExtractsRatsRats, Inbred LewAnti-Inflammatory AgentsInflammation MediatorsInterferon-gammaInterleukin-17Matrix Metalloproteinase InhibitorsPlant Extractsadjuvant arthritisautoimmunitybone remodelingchemokinescytokinesnatural productsrheumatoid arthritisTinospora cordifolia

Identifiers

PMID26467057
PMCPMC8082752
OpenAlexW2281945934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.